Literature DB >> 10603941

Molecular regulation of phospholamban function and gene expression.

M Tada1, M Yabuki, T Toyofuku.   

Abstract

Ca-ATPase regulates intracellular Ca levels by pumping Ca into sarcoplasmic reticulum. Phospholamban (PLN) functions as an inhibitory cofactor for cardiac Ca-ATPase (SERCA2). To define the molecular mode of interaction between two proteins, interaction sites have been identified. Studies using photoactivated cross-linker and chimeric Ca-ATPase between SERCA2 and nonmuscle Ca-ATPase (SERCA3) indicated that potential binding residues are located just downstream of the active ATPase site (Asp351) of SERCA2. Site-directed mutagenesis study of this region showed that six residues, Lys-Asp-Asp-Lys-Pro-Val402, of SERCA2 are functionally important for the interaction. Further, mutagenesis study of PLN showed that the cytoplasmic region of PLN contains a potential binding site with SERCA2. The unique expression of PLN in cardiac cells has been analyzed by the transcriptional level of its gene using luciferase activity and Gel shift assays. CCAAT-box in the 5'-upstream region was found to be essential for its expression by associating with Y-box binding transcriptional factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10603941     DOI: 10.1111/j.1749-6632.1998.tb08261.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  HuR regulates phospholamban expression in isoproterenol-induced cardiac remodelling.

Authors:  Han Hu; Mingyang Jiang; Yangpo Cao; Zhuojun Zhang; Bin Jiang; Feng Tian; Juan Feng; Yali Dou; Myriam Gorospe; Ming Zheng; Lemin Zheng; Zhongzhou Yang; Wengong Wang
Journal:  Cardiovasc Res       Date:  2020-04-01       Impact factor: 10.787

2.  Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray.

Authors:  J David Barrans; Paul D Allen; Dimitrios Stamatiou; Victor J Dzau; Choong-Chin Liew
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.